Chronic Exposure to Carbon Nanotubes Induces Invasion of Human Mesothelial Cells through Matrix Metalloproteinase-2
Source abstract
Abstract
Malignant mesothelioma is one of the most aggressive forms of cancer known. Recent studies have shown that carbon nanotubes (CNTs) are biopersistent and induce mesothelioma in animals, but the underlying mechanisms are not known. Here, we investigate the effect of long-term exposure to high aspect ratio CNTs on the aggressive behaviors of human pleural mesothelial cells, the primary cellular target of human lung mesothelioma. We show that chronic exposure (4 months) to single- and multiwalled CNTs induced proliferation, migration, and invasion of the cells similar to that observed in asbestos-exposed cells. An up-regulation of several key genes known to be important in cell invasion, notably matrix metalloproteinase-2 (MMP-2), was observed in the exposed mesothelial cells as determined by real-time PCR. Western blot and enzyme activity assays confirmed the increased expression and activity of MMP-2. Whole genome microarray analysis further indicated the importance of MMP-2 in the invasion gene signaling network of the exposed cells. Knockdown of MMP-2 in CNT and asbestos-exposed cells by shRNA-mediated gene silencing effectively inhibited the aggressive phenotypes. This study demonstrates CNT-induced cell invasion and indicates the role of MMP-2 in the process.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Occupational and environmental lung diseases · Graphene and Nanomaterials Applications · Protease and Inhibitor Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505, United States
References (71)
Show source-provided references
1. Shvedova A. A. · Pharmacol. Ther. · 2009 · 121 · 19210.1016/j.pharmthera.2008.10.009 ↗
2. Helland A. · Environ. Health Perspect. · 2007 · 115 · 112510.1289/ehp.9652 ↗
3. Donaldson K. · Nanomedicine · 2011 · 6 · 14310.2217/nnm.10.139 ↗
4. Elgrabli D. · Part. Fibre Toxicol. · 2008 · 5 · 2010.1186/1743-8977-5-20 ↗
5. Donaldson K. · Part. Fibre Toxicol. · 2010 · 7 · 510.1186/1743-8977-7-5 ↗
6. Chou C. C. · Nano Lett. · 2008 · 8 · 43710.1021/nl0723634 ↗
7. Lam C. W. · Toxicol. Sci. · 2004 · 77 · 12610.1093/toxsci/kfg243 ↗
8. Muller J. · Toxicol. Appl. Pharmacol. · 2005 · 207 · 22110.1016/j.taap.2005.01.008 ↗
9. Murphy F. A. · Nanotoxicology · 2013 · 7 · 115710.3109/17435390.2012.713527 ↗
10. Mercer R. R. · Part. Fibre Toxicol. · 2010 · 7 · 2810.1186/1743-8977-7-28 ↗
11. Yang H. · Curr. Treat. Options Oncol. · 2008 · 9 · 14710.1007/s11864-008-0067-z ↗
12. Puhakka A. · Mutat. Res. · 2002 · 514 · 710.1016/S1383-5718(01)00322-9 ↗
13. Pacurari M. · Environ. Health Perspect. · 2008 · 116 · 121110.1289/ehp.10924 ↗
14. Kaiser J. P. · J. Mater. Sci. Mater. Med. · 2008 · 19 · 152310.1007/s10856-007-3296-y ↗
15. Tabet L. · J. Toxicol. Environ. Health A · 2009 · 72 · 6010.1080/15287390802476991 ↗
16. Bozzuto G. · Ann. Ist. Super. Sanita · 2010 · 46 · 66
17. Horwitz R. · Curr. Biol. · 2003 · 13 · R75610.1016/j.cub.2003.09.014 ↗
18. Friedl P. · Nat. Rev. Cancer · 2003 · 3 · 36210.1038/nrc1075 ↗
19. Mercer R. R. · Am. J. Physiol. Lung Cell Mol. Physiol. · 2008 · 294 · L8710.1152/ajplung.00186.2007 ↗
20. Shvedova A. A. · Am. J. Physiol. Lung Cell Mol. Physiol. · 2005 · 289 · L69810.1152/ajplung.00084.2005 ↗
21. Stone K. C. · Am. J. Respir. Cell Mol. Biol. · 1992 · 6 · 23510.1165/ajrcmb/6.2.235 ↗
22. Takeuchi T. · Mutat. Res. · 1999 · 438 · 6310.1016/S1383-5718(98)00163-6 ↗
23. Brown J. S. · Am. J. Respir. Crit. Care Med. · 2002 · 166 · 124010.1164/rccm.200205-399OC ↗
24. Shvedova A. A. · Am. J. Physiol. Lung Cell Mol. Physiol. · 2008 · 295 · L55210.1152/ajplung.90287.2008 ↗
25. Li X. · Nucleic Acids Res. · 2006 · 34 · 367010.1093/nar/gkl513 ↗
26. Sargent L. M. · Mutat. Res. · 2012 · 745 · 2810.1016/j.mrgentox.2011.11.017 ↗
27. Xu J. · Cancer Sci. · 2012 · 103 · 204510.1111/cas.12005 ↗
28. Heintz N. H. · Am. J. Respir. Cell Mol. Biol. · 2010 · 42 · 13310.1165/rcmb.2009-0206TR ↗
29. Sharma C. S. · J. Nanosci. Nanotechnol. · 2007 · 7 · 246610.1166/jnn.2007.431 ↗
30. Cho S. Y. · J. Cell Biol. · 2000 · 149 · 22310.1083/jcb.149.1.223 ↗
31. Friedl P. · Cell. Mol. Life Sci. · 2000 · 57 · 4110.1007/s000180050498 ↗
32. Wang L. · Nano Lett. · 2011 · 11 · 279610.1021/nl2011214 ↗
33. Lee A. G. · Toxicol. Pathol. · 1997 · 25 · 56510.1177/019262339702500605 ↗
34. Tamaoki J. · Am. J. Physiol. Lung Cell Mol. Physiol. · 2004 · 287 · L112710.1152/ajplung.00241.2004 ↗
35. Lauffenburger D. A. · Cell · 1996 · 84 · 35910.1016/S0092-8674(00)81280-5 ↗
36. Guo N. L. · J. Toxicol. Environ. Health A · 2012 · 75 · 112910.1080/15287394.2012.699852 ↗
37. Park E. J. · Arch. Toxicol. · 2011 · 85 · 112110.1007/s00204-011-0655-8 ↗
38. Passlick B. · Clin. Cancer Res. · 2000 · 6 · 3944
39. Tan R. J. · Am. J. Respir. Cell Mol. Biol. · 2006 · 35 · 28910.1165/rcmb.2005-0471OC ↗
40. Stetler-Stevenson W. G. · Annu. Rev. Cell Biol. · 1993 · 9 · 54110.1146/annurev.cb.09.110193.002545 ↗
41. Nagase H. · J. Biol. Chem. · 1999 · 274 · 2149110.1074/jbc.274.31.21491 ↗
42. Birkedal-Hansen H. · Crit. Rev. Oral Biol. Med. · 1993 · 4 · 19710.1177/10454411930040020401 ↗
43. Coussens L. M. · Chem. Biol. · 1996 · 3 · 89510.1016/S1074-5521(96)90178-7 ↗
44. Wang A. · BMC Cancer · 2008 · 8 · 18210.1186/1471-2407-8-182 ↗
45. Shen Y. G. · Dig. Dis. Sci. · 2012 · 57 · 3210.1007/s10620-011-1864-y ↗
46. Masson V. · FASEB · 2004 · 19 · 234
47. Tokuraku M. · Int. J. Cancer · 1995 · 64 · 35510.1002/ijc.2910640513 ↗
48. Suzuki M. · J. Biol. Chem. · 2004 · 279 · 1489910.1074/jbc.M313130200 ↗
49. Li H. · J. Cell. Biochem. · 2013 · 114 · 65010.1002/jcb.24407 ↗
50. Mi Z. · Carcinogenesis · 2006 · 27 · 113410.1093/carcin/bgi352 ↗
51. Xie T. X. · Cancer Res. · 2006 · 66 · 318810.1158/0008-5472.CAN-05-2674 ↗
52. Xie T. X. · Oncogene · 2004 · 23 · 355010.1038/sj.onc.1207383 ↗
53. Yu C. L. · Science · 1995 · 269 · 8110.1126/science.7541555 ↗
54. Jin E. J. · J. Cell. Biochem. · 2007 · 102 · 25210.1002/jcb.21430 ↗
55. Park B. K. · Cancer Res. · 2001 · 61 · 7647
56. Hu J. · Exp. Ther. Med. · 2012 · 4 · 104510.3892/etm.2012.702 ↗
57. Murphy G. · Curr. Opin. Cell Biol. · 1999 · 11 · 61410.1016/S0955-0674(99)00022-8 ↗
58. Kohn E. C. · Cancer Res. · 1995 · 55 · 1856
59. Grigioni W. F. · Mol. Pathol. · 1994 · 7 · 220
60. Sáinz-Jaspeado M. · Cancer Res. · 2010 · 8 · 1489
61. Tanaka S. · Exp. Lung Res. · 2000 · 26 · 24110.1080/019021400404528 ↗
62. Shvedova A. A. · Am. J. Respir. Cell Mol. Biol. · 2008 · 38 · 57910.1165/rcmb.2007-0255OC ↗
63. Ahmed S. · Arthritis Rheum. · 2006 · 54 · 239310.1002/art.22023 ↗
64. Pan J. · Chem. Res. Toxicol. · 2010 · 23 · 56810.1021/tx9003193 ↗
65. Habibzadegah-Tari P. · Urol. Res. · 2006 · 34 · 2610.1007/s00240-005-0007-3 ↗
66. Wang L. · Part. Fibre Toxicol. · 2010 · 7 · 3110.1186/1743-8977-7-31 ↗
67. 10.3109/17435390.2013.80108910.3109/17435390.2013.801089 ↗
68. 10.1155/2012/93093110.1155/2012/930931 ↗
69. Porter D. W. · Toxicology · 2010 · 269 · 13610.1016/j.tox.2009.10.017 ↗
70. Kesanakurti D. · Oncogene · 2013 · 32 · 32710.1038/onc.2012.52 ↗
71. Stueckle T. A. · Toxicol. Appl. Pharmacol. · 2012 · 261 · 20410.1016/j.taap.2012.04.003 ↗